Results 221 to 230 of about 187,331 (234)

Modification of the association between alcohol drinking and non-HDL cholesterol by gender

Clinica Chimica Acta, 2009
Ichiro Wakabayashi, Klaus Gröschner
exaly  

Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention

Atherosclerosis, 2018
Eun Young Lee, Yeoree Yang, Hun-Sung Kim   +2 more
exaly  

Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study

European Journal of Preventive Cardiology, 2020
Renato Quispe, Mohamed B Elshazly, Di Zhao   +2 more
exaly  

A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2

Atherosclerosis, 2012
Raúl D Santos, David D Waters, Michael Messig   +2 more
exaly  

Trajectories of Non–HDL Cholesterol Across Midlife

Journal of the American College of Cardiology, 2019
Karol M Pencina, George Thanassoulis, John T Wilkins   +2 more
exaly  

TRIGLYCERIDES’ IMPACT ON NON-HDL-C LEVELS IN HIGH CARDIOVASCULAR RISK

Atherosclerosis
Duaa Al Nahari, Wael Al Mahmeed, Ahmed Al-Sarraf, Manal Al Kindi, Fatheya Al Awadi, Mahmoud Zirie, Haitham Amin, Hani Sabbour, Nader Lessan, Alia Al Tikriti, Khalid Al Waili, Obada Salameh, Ibrahim Al-Zakwani, Khalid Al-Rasadi   +13 more
openaire   +1 more source

The Role of Non-HDL Cholesterol in Risk Stratification for Coronary Artery Disease

Current Atherosclerosis Reports, 2011
Jamal S Rana, S Matthijs Boekholdt, Prediman K Shāh   +2 more
exaly  

M.458 Effects of switching statins on non-HDL-C in hypercholesterolaemic patients and achievement of ATP III combined LDL-C and non-HDL-C goals in patients with elevated triglycerides: Mercury I trial results

Atherosclerosis, 2004
P. Barter, S. Stender, J. Morrell, R. Caplan, J. Blasetto   +4 more
openaire   +2 more sources

Circulating non–HDL-C levels were more relevant to atherogenic lipoprotein subfractions compared with LDL-C in patients with stable coronary artery disease

Journal of Clinical Lipidology, 2015
Cheng-Gang Zhu, Rui-Xia Xu, Na-Qiong Wu   +2 more
exaly  

Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raisingA systematic review and meta-analysis of relevant preclinical studies and clinical trials

European Journal of Pharmacology, 2015
JOSÉ W A Van Der Hoorn, Hans M G Princen, J Wouter Jukema   +2 more
exaly